Acadian Asset Management LLC Praxis Precision Medicines, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.87 - $1.71 $94,606 - $185,950	-108,743 Reduced 7.05%	1,434,474 $2.45 Million
Q2 2023 Aug 07, 2023	BUY	$0.83 - $1.18 $121,852 - $173,235	146,810 Added 10.51%	1,543,217 $1.77 Million
Q1 2023 May 11, 2023	BUY	$0.8 - $4.98 $34,301 - $213,527	42,877 Added 3.17%	1,396,407 $1.13 Million
Q4 2022 Feb 14, 2023	BUY	$1.88 - $36.45 $623,913 - $12.1 Million	331,869 Added 32.48%	1,353,530 $3.22 Million
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $481,360 - $7.31 Million	192,544 Added 23.22%	1,021,661 $2.32 Million
Q2 2022 Aug 09, 2022	BUY	$1.75 - $11.34 $1.45 Million - $9.4 Million	829,117 New	829,117 $2.03 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.